Robust Growth of Global Endoscopy Devices Market Attributed to Increasing Demand for Minimally Invasive Surgeries

Albany – New York: Biological drugs are derived from living cells and are an advanced type of medicines utilized for easing the symptoms of various diseases. Biological drugs include monoclonal antibodies (mAb) and vaccines. These drugs are commonly prescribed if the patient doesn’t benefit much from other medicines such as disease-modifying anti-rheumatic drugs (DMARDs). The various diseases that can be cured by biological drugs include HIV/AIDS, asthma, cancer, Alzheimer’s disease, diabetes, inflammatory diseases, irritable bowel syndrome, and rheumatoid arthritis.

Rise in Geriatric Population to Fuel Biological Drugs Market

The rise in geriatric population and increasing occurrence of chronic diseases has fueled the market for biological drugs. A number of government-run organizations have promoted the usage of biological drugs and development in biomedical sciences through funding research and supporting various private and public organizations, which is further augmenting the demand for biological drugs. Furthermore, the introduction of highly efficient new and advanced drugs has stimulated the growth of the biological drugs market. On the other hand, there are a number of factors inhibiting the growth of the biological drugs market. These factors include risks associated with injectable biological drugs, high costs of the drugs, and patent expiry of various biological drugs.

Enbrel: The Biggest and Most Swiftly Developing Therapeutic Protein

On the basis of therapeutic protein, the biological drugs market is segmented into Levemir, Eylea, Neulasta, Novolog, Rebif, Avonex, Enbrel, Neupogen, Victoza, Humalog, Epogen, Lantus, Betaseron, and Aranesp. Amongst these, Enbrel is the most swiftly developing therapeutic protein. On the basis of monoclonal antibody (MAb), the biological market is segmented into Avastin, Lucentis, Rituxan, Herceptin, Humira, and Remicade. Within the monoclonal antibody (mAb), Humira is the biggest and the most swiftly developing mAb. On the basis of vaccine, the market is segmented into Gardasil, Cervarix, Fluzone, Varivax, and Prevnar 13. Amongst these, Prevnar 13 is the biggest and the most swiftly developing vaccine.

North America Biological Drugs Market Emerges as the Biggest Market

On the basis of geography, the biological drugs market is segmented into North America, Europe, Asia Pacific, and Rest of the World (RoW). Amongst these, North America led the global market for biological drugs. This is owing to the rising usage of biological drugs in the treatment of diseases such as diabetes, cancer, and other chronic diseases. A large number of government associations have promoted the utilization of these drugs in North America. For example, the American College of Rheumatology, a body that has advanced rheumatology via research and education, has supported the usage of disease-modifying antirheumatic drugs in 2012 for treating rheumatoid arthritis.

On the other hand, the market for biological drugs is also developing exponentially in Europe owing to a rise in the aging population. The aging population in Europe suffers from a number of diseases, including macular degeneration and glaucoma. These are effectively treated by the usage of biological drugs.

Abbott Laboratories, Pfizer Inc., Novartis AG, GlaxoSmithKline plc., Eli Lilly and Company,  Bristol-Myers Squibb Company, Amgen Inc., Merck & Co., Inc., Biogen Idec, and Baxter International Inc.,  among others are the major players operating in the market for biological drugs.

Source: www.transparencymarketresearch.com/endoscopy-devices-market.html

Related Posts Plugin for WordPress, Blogger...